Alpine Immune Sciences Inc (ALPN)
65.00
+0.04
(+0.06%)
USD |
NASDAQ |
May 17, 16:00
65.00
0.00 (0.00%)
After-Hours: 20:00
Alpine Immune Sciences Cash and Short Term Investments (Annual): 327.41M for Dec. 31, 2023
Cash and Short Term Investments (Annual) Chart
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 327.41M |
| December 31, 2022 | 237.64M |
| December 31, 2021 | 162.30M |
| December 31, 2020 | 105.58M |
| December 31, 2019 | 40.52M |
| December 31, 2018 | 52.30M |
| Date | Value |
|---|---|
| December 31, 2017 | 81.24M |
| December 31, 2016 | 61.04M |
| December 31, 2015 | 87.25M |
| December 31, 2014 | 27.81M |
| December 31, 2013 | 1.098M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Annual) Range, Past 5 Years
40.52M
Minimum
2019
327.41M
Maximum
2023
174.69M
Average
162.30M
Median
2021
Cash and Short Term Investments (Annual) Benchmarks
| Vertex Pharmaceuticals Inc | 11.22B |
| Eliem Therapeutics Inc | 106.80M |
| Regeneron Pharmaceuticals Inc | 10.84B |
| Vera Therapeutics Inc | 160.72M |
| Eyenovia Inc | 14.85M |